Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Bemotrizinol, the First New Sunscreen Option in over 25 Years
We examine bemotrizinol, the first new sunscreen option in over 25 years, including its broad-spectrum protection, minimal skin absorption and unanswered environmental questions. Dr. Chow also covers recovery from lung cancer surgery, a study linking high ultra-processed food intake with brain changes in Canadian adults, and research on GLP-1 drugs beyond weight-loss.
Key Points
- Bemotrizinol has been approved in the United States, offering broad-spectrum UVA and UVB protection with good sunlight stability and minimal skin absorption.
- A study of more than 8,700 Canadian adults found that higher intake of ultra-processed foods was associated with brain changes that may raise the risk of stroke, dementia, and cognitive decline.
- GLP-1 medications such as semaglutide may provide benefits beyond weight loss, including improved heart, kidney, liver, lung, and joint outcomes, while some batches of Flintstones vitamins, Aleve, and Claritin have been recalled in Canada because of a distribution error.
Chapters
| 0:00 | |
| 6:24 | |
| 10:51 |
Transcript
Loading transcript...
- / -